“They will not all be evaluated in clinical trials with the necessary rigor,” said Dr. William Moss, executive director of the Johns Hopkins International Vaccine Access Center.
An exception to the U.S. rule is people who received a full series of the Novavax vaccine in a late-stage study. The U.S. is accepting the participants who received the vaccine, not a placebo, because it was a rigorous study with oversight from an independent monitoring board.
The U.S. also allows entry to people who got two doses of any “mix-and-match” combination of vaccines on the FDA and WHO lists.
The AP is answering your questions about the coronavirus in this series. Submit them at: FactCheck@AP.org. Read more here:
Can at-home COVID-19 tests make holiday gatherings safer?
Are COVID-19 boosters the same as the original vaccines?
Can I get the flu and COVID-19 vaccines at the same time?
For more content like this, sign up for the Pulse newsletter here.